Cargando…

Antiviral drugs against hepatitis C virus

Hepatitis C virus (HCV) infection is a major worldwide problem causes acute and chronic HCV infection. Current treatment of HCV includes pegylated interferon-α (PEG IFN- α) plus ribavirin (RBV) which has significant side effects depending upon the type of genotype. Currently, there is a need to deve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rehman, Sidra, Ashfaq, Usman A, Javed, Tariq
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136400/ https://www.ncbi.nlm.nih.gov/pubmed/21699699 http://dx.doi.org/10.1186/1479-0556-9-11

Ejemplares similares

In-vitro antiviral activity of Solanum nigrum against Hepatitis C Virus
por: Javed, Tariq, et al.
Publicado: (2011)

Antiviral activity of Acacia nilotica against Hepatitis C Virus in liver infected cells
por: Rehman, Sidra, et al.
Publicado: (2011)

Post-transcriptional inhibition of hepatitis C virus replication through small interference RNA
por: Ali Ashfaq, Usman, et al.
Publicado: (2011)

Glycyrrhizin as antiviral agent against Hepatitis C Virus
por: Ashfaq, Usman A, et al.
Publicado: (2011)

Inhibition of full length Hepatitis C Virus particles of 1a genotype through small interference RNA
por: Ansar, Muhammad, et al.
Publicado: (2011)

An overview of HCV molecular biology, replication and immune responses
por: Ashfaq, Usman A, et al.
Publicado: (2011)

Hepatitis C virus to hepatocellular carcinoma
por: Jahan, Shah, et al.
Publicado: (2012)

Hepatitis C Virus and Antiviral Drug Resistance
por: Kim, Seungtaek, et al.
Publicado: (2016)

Lysosomotropic agents as HCV entry inhibitors
por: Ashfaq, Usman A, et al.
Publicado: (2011)

Drug Delivery Strategies for Antivirals against Hepatitis B Virus
por: Singh, Latavia, et al.
Publicado: (2018)

siRNAs: Potential therapeutic agents against Hepatitis C Virus
por: Ashfaq, Usman A, et al.
Publicado: (2011)

Inhibition of HCV 3a core gene through Silymarin and its fractions
por: Ashfaq, Usman Ali, et al.
Publicado: (2011)

Plant-derived antivirals against hepatitis c virus infection
por: Jardim, Ana Carolina Gomes, et al.
Publicado: (2018)

Phytochemical profiling and antiviral activity of Ajuga bracteosa, Ajuga parviflora, Berberis lycium and Citrus lemon against Hepatitis C Virus
por: Yousaf, Tahir, et al.
Publicado: (2018)

In-vitro model systems to study Hepatitis C Virus
por: Ashfaq, Usman Ali, et al.
Publicado: (2011)

Antiviral Activity of Glycyrrhizin against Hepatitis C Virus In Vitro
por: Matsumoto, Yoshihiro, et al.
Publicado: (2013)

Current Status of Direct Acting Antiviral Agents against Hepatitis C Virus Infection in Pakistan
por: Khaliq, Saba, et al.
Publicado: (2018)

Effectiveness of direct-acting antiviral drugs against hepatitis C virus: predictive factors of response to the treatment
por: Cárdaba-García, María E., et al.
Publicado: (2021)

Efficacy of Antiviral Drugs against Feline Immunodeficiency Virus
por: Hartmann, Katrin, et al.
Publicado: (2015)

Prospects for personalizing antiviral therapy for hepatitis C virus with pharmacogenetics
por: Tavis, John E, et al.
Publicado: (2011)

Antiviral Therapy for Hepatitis C Virus: Beyond the Standard of Care
por: Delang, Leen, et al.
Publicado: (2010)

Hepatitis C Virus Infection: Molecular Pathways to Insulin resistance
por: Parvaiz, Fahed, et al.
Publicado: (2011)

The Hepatitis C Virus Nonstructural Protein 2 (NS2): An Up-and-Coming Antiviral Drug Target
por: Lorenz, Ivo C.
Publicado: (2010)

Antiviral Activity of Zinc Oxide Nanoparticles and Tetrapods Against the Hepatitis E and Hepatitis C Viruses
por: Gupta, Jyoti, et al.
Publicado: (2022)

Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection
por: Salama, Iman Ibrahim, et al.
Publicado: (2022)

Iron Regulator Hepcidin Exhibits Antiviral Activity against Hepatitis C Virus
por: Liu, Hongyan, et al.
Publicado: (2012)

Antiviral Profile of Brown and Red Seaweed Polysaccharides Against Hepatitis C Virus
por: Gheda, Saly F., et al.
Publicado: (2016)

Direct-acting antiviral agents against hepatitis C virus and lipid metabolism
por: Kanda, Tatsuo, et al.
Publicado: (2017)

Quinolinate Phosphoribosyltransferase is an Antiviral Host Factor Against Hepatitis C Virus Infection
por: Wang, Zhilong, et al.
Publicado: (2017)

Hepatitis C Virus and Natural Compounds: a New Antiviral Approach?
por: Calland, Noémie, et al.
Publicado: (2012)

Hepatitis C virus infection in children in the era of direct-acting antiviral
por: Pawlowska, Malgorzata, et al.
Publicado: (2018)

Screening of drug candidates against Endothelin-1 to treat hypertension using computational based approaches: Molecular docking and dynamics simulation
por: Fatima, Israr, et al.
Publicado: (2022)

Antiviral strategies for hepatitis E virus
por: Debing, Yannick, et al.
Publicado: (2014)

Antivirals against the Chikungunya Virus
por: Battisti, Verena, et al.
Publicado: (2021)

The Insight of In Silico and In Vitro evaluation of Beta vulgaris phytochemicals against Alzheimer’s disease targeting acetylcholinesterase
por: Rehman, Sidra, et al.
Publicado: (2022)

Sensitivity of a Ribavirin Resistant Mutant of Hepatitis C Virus to Other Antiviral Drugs
por: Mihalik, Kathleen B., et al.
Publicado: (2013)

Antiviral Treatment for Hepatitis C Virus Infection after Liver Transplantation
por: Sugawara, Yasuhiko, et al.
Publicado: (2010)

Drug–Drug Interactions of Newly Approved Direct-Acting Antiviral Agents in Patients with Hepatitis C
por: Gao, Lu-Hua, et al.
Publicado: (2021)

Direct-Acting Antiviral Agents for Hepatitis C Virus Infection—From Drug Discovery to Successful Implementation in Clinical Practice
por: Dietz, Christopher, et al.
Publicado: (2022)

Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus
por: Kanda, Tatsuo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0etp1ba04uji36oqo1u02ceeme